Takotsubo Syndrome Revisited: Findings From a Multicenter Cohort Study

Category	Detail
Condition	Takotsubo syndrome (TTS), a cardiac syndrome characterized in this study by wall motion abnormalities and new ECG changes or troponin elevation.
Key Mechanisms	Pathophysiology remains incompletely understood; proposed contributors include excess circulating or locally released catecholamines, adrenoreceptor modulation, coronary spasm, endothelial dysfunction, and brain–heart axis interactions.
Target Population	Adults aged 18 years or older diagnosed with TTS at 13 German tertiary care centers from January 2013 through December 2024.
Care Setting	Retrospective multicenter study in German tertiary care centers, examining in-hospital complications and short-term cardiac recovery.

The study classified presumed triggers as acute neurologic, other physical, emotional, or not identifiable.
Acute neurologic triggers included stroke, subarachnoid hemorrhage, seizure or status epilepticus, other intracranial hemorrhage, and acute migraine.
The composite in-hospital cardiac-complication endpoint included new atrial fibrillation, VT/VF, pulmonary edema, cardiogenic shock, or death.
Admission assessment recorded LVEF, wall motion pattern, and right ventricular function.
The study aimed to compare cardiac dysfunction by trigger type, examine short-term recovery, and identify patients vulnerable to critical in-hospital courses.

In the study, TTS was identified by wall motion abnormalities together with new ECG changes or troponin elevation.
Admission assessment included left ventricular ejection fraction (LVEF), wall motion pattern, and right ventricular function.
Presumed triggers were categorized as acute neurologic, other physical, emotional, or not identifiable.

The provided source describes study design and assessment methods, not specific treatment recommendations.
Management should not be inferred from this study excerpt; it does not compare therapies or establish a treatment protocol.

The study assessed in-hospital cardiac complications, including new atrial fibrillation, VT/VF, pulmonary edema, cardiogenic shock, and death.
Short-term cardiac recovery was examined, including changes in cardiac function; the excerpt does not specify a follow-up schedule or monitoring protocol.

Potential in-hospital complications assessed included arrhythmias (new atrial fibrillation and VT/VF), pulmonary edema, cardiogenic shock, and death.
The study sought to identify patients vulnerable to critical in-hospital courses and compare cardiac dysfunction across trigger categories.

Adults aged 18 years or older with TTS treated at 13 German tertiary care centers between January 2013 and December 2024.

The provided article excerpt reports study design and assessment methods but does not provide medication or treatment recommendations.

Assess cardiac function at admission, including LVEF, wall motion pattern, and right ventricular function.
Document the presumed trigger, distinguishing acute neurologic, other physical, emotional, and unidentified triggers.
Monitor for the in-hospital complications evaluated in the study: new atrial fibrillation, VT/VF, pulmonary edema, cardiogenic shock, and death.
Evaluate short-term cardiac recovery, while recognizing that the study excerpt does not specify a monitoring schedule or treatment protocol.

Original multicenter cohort study: “Takotsubo Syndrome Revisited: Findings From a Multicenter Cohort Study.”
Related topics in the source include neurologic and physical triggers of TTS, cardiac dysfunction and recovery, and in-hospital complications.